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Foreword 
At the 1998 Mid-Term Meeting (MTM) of the Consultative Group on 
International Agricultural Research (CGIAR), held in Brazil, the Center 
Board Chairs (CBC) and the Center Directors (CDC) Committees jointly 
submitted eight documents relating to genetic resources, biotechnology, 
and intellectual property rights. Their letter included the statement, 
“The Centers are convinced of the need for consistent policies and 
procedures across the System. The Centers are further convinced of the 
need to make public the policies, and urge, therefore, that they be 
endorsed at MTM’98.” They further added, “The statements that are 
attached refer to Center policies and procedures which will-indeed 
must-be carried out within the aegis of all relevant national and 
international laws and agreements.” 
At International Centers Week 1998, held in Washington, DC, the 
CBC, CDC, and Food and Agriculture Organization (FAO) provided 
three further documents: 
l Guidelines for the Designation of Accessions under the FAO Agreements; 
l MaterialTransfer Agreement;and 
l Second Joint Statement on the Agreement Placing CGIAR Germplasm Collections 
under the Auspices of FAO. 
These three documents were endorsed for CGIAR System-wide use 
by the CBC, CDC, and the Genetic Resources Policy Committee. 
All of the documents referred to above are presented in this 
publication. Work is ongoing to develop further the Guiding Principles 
for the CGIAR Centers on Intellectual Property and Genetic Resources. 
When available, an update will be provided. 
MTM’99 
May 1999 
Beijing, Chica 
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CGIAR Centers’ Position 
Statement on Genetic Resources, 
Intellectual Property Rights, 
and Biotechnology 
The CGIAR has a set of policies and instruments to guide and 
provide coherence to its work with genetic resources. These now include: 
1. CGIAR-endorsed Ethical Principles Relating to Genetic Resources, addressing the 
subjects of equity; trusteeship of genetic resources; respect, responsibility,and 
integrity in science; and social benefits. 
2. Agreements with FAO covering 500,000 accessions of plant germplasm.The 
international Plant Genetic Resources Institute (IPGRI),on behalf of the CGIAR, will 
continue to work with FAO to address issues concerning the interpretation and 
implementation of these Agreements. In addition, IPGRI, in consultation with other 
Centers through the System-wide Genetic Resources Program,will complete a set 
of draft guidelines on designation by September 1998,to assist Centers in 
determining which materials to place under the Agreements with FAO. 
3. A common Germplasm Acquisition Agreement for use in acquiring materials 
intended for designation under the Agreements with FAO. 
4. A common MaterialTransfer Agreement (MTA) for designated germplasm. IPGRI 
shall keep a watching brief on the efficacy of the MTA in implementing the FAO- 
CGIAR Agreements, and, in consultation with FAO and the Centers, propose any 
changes in the MTA which might be needed in the future. Revisions to the MTA will 
be adopted and implemented on a System-wide basis. 
5. A statement,endorsed by the Genetic Resources Policy Committee,the Center 
Directors Committee (CDC), and the Center Board Chairs Committee (CBC), on the 
steps Centers will take when they believe that a MaterialTransfer Agreement may 
have been violated. 
6. Guiding Principles on Intellectual Property Rights,which will be further discussed 1' 
and developed under the leadership of the CDC Committee on IPR, with the aim 
that a revised draft will be ready by International Centers’ Week (ICW), 1999. 
7. An agreed statement on Principles Involving Center Interaction with the Private 
Sector and Others on ProprietaryTechnology. 
8. An agreed position statement on Biotechnology. 
The CGIAR’s Ethical 
Principles Relating to 
Genetic Resources 
Introduction 
The CGIAR was founded on the ethical imperative of eliminating 
hunger and starvation and has, since its inception, followed certain 
ethical principles. Increasing food security f and alleviating poverty have 
long been central to the System’s science-based humanitarian mission. 
With the growing complexity of the problems being addressed by the 
research of the Centers, the expanding number of partners with whom 
they work, and the rapidly evolving scientific, social, and economic 
environment within which they operate, an increasing need has been felt 
for a cleared enunciation of the System’s underlying ethical principles. 
Greater transparency about what the CGIAR really stands for is 
important in enabling strong and unambiguous relationships to be 
forged with a wide range of partners. 
The main ethical principles are presented under four headings: 
Equity; Trusteeship of Genetic Resources; Respect, Responsibility, and 
Integrity in Science; and Social Benefits. These are intended to 
encapsulate the essential principles followed by the CGIAR in relation to 
its work on genetic resources and in the pursuance of its goal: to 
contribute through agricultural and natural resources research and 
partnerships to sustainable food security and the alleviation of poverty. 
Equity 
l The CGIAR works for the attainment of equity in the conservation,sustainable use, 
and the sharing of benefits derived from genetic resources.This commitment to 
fairness requires that emphasis be given to the needs of resource-poor 
communities and to disadvantaged members of society. 
t According to the definition in the World Food Summit Plan of Action, food security exists when ail 
people, at all times, have physical and economic access to sufficient, safe, and nutritious food to 
meet their dietary needs and food preferences for an active and healthy life. 
l The CGIAR recognizes the contribution of many different communities and 
individuals, especially of women, to the conservation and enhancement of genetic 
diversity of potential use for food and agriculture, and will strive to ensure they 
benefit from such contributions.The CGIAR will avoid situations where a 
foreseeable reduction of local communities’access to, and benefits from, genetic 
resources might occur. 
l The CGIAR recognizes that its major strength lies in its partnerships with national 
agricultural research systems and other organizations, and is committed to sharing 
credit in an equitable manner, 
Trusteeship of Genetic Resources 
l The CGIAR Centers hold genetic resources in trust for the international community. 
In the case of plant genetic resources for food and agriculture this is, to a great 
extent, recognized through agreements with FAO. As trustees of genetic resources 
the CGIAR Centers recognize their responsibility to be impartial,transparent,and 
fair in their administration of the trust;to respect and observe national regulations 
and international conventions, in particular the Convention on Biological Diversity; 
to be accountable for their actions; and to exercise due care and diligence in 
conserving the material for the use of present and future generations and in 
making it readily available for use for the public good. 
Respect, Responsibility, and 
Integrity in Science 
l The CGIAR’s work on genetic resources respects the general scientific principles of 
good faith and the search for truth. However, the CGIAR is guided by its particular 
humanitarian end equity-based concerns,and not the pursuit of knowledge for its 
own sake. 
l The CGIAR’s scientific work, including that on biotechnology, is based on the 
principles of accountability, responsibility, and precautionary action. For any 
undertaking, potential benefits shall clearly outweigh foreseeable risks, 
emphasizing broad societal interests such as food security, poverty alleviation, and 
environmental sustainability. 
l The CGIAR recognizes and respects the integrity of culture, tradition, and the 
relationship of local people with their natural environments. Likewise the CGIAR 3. 
respects the aspirations and culture of partner institutions and the societal context 
within which they operate. 
l The CGIAR adheres to national regulations and to relevant internationally accepted 
codes of behavior and conduct in areas of plant and animal biology;the collection 
and transfer of g-enetic resources; biosafety; animal welfare; and intellectual 
property. 
Social Benefits 
l The CGIAR aims to promote lasting social benefit through its research and 
partnerships for the international public good. In its activities on genetic resources 
the CGIAR strives to increase individual, local, and national food and livelihood 
security in developing countries through sustainable advances in productivity, 
nutritional quality,stability,and through promoting biological and food diversity. 
For this purpose it is accountable for the dimensions of social and gender equity 
and environmental sustainability in its research, human resource development, and 
capacity building programs.The CGIAR aims to support the building of national 
capacity and institutions to manage, develop, and conserve genetic resources. 
Conclusion 
The above principles, while not exhaustive, are intended to provide 
an overall statement of ethical principles relating to the CGIAR’s work 
in genetic resources. They are also intended to provide a basis on which 
individual Centers can further elaborate their own guiding ethical 
principles or codes of conduct, and set up monitoring mechanisms, as 
appropriate. In implementing the above principles, the CGIAR Centers 
will work in partnership with national systems and other relevant 
organizations. 
Endorsed by the CC/AR Genetic 
Resources Policy Committee, 
Moy4,1998 
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Agreement between [Name of Center] 
and the Food and Agriculture 
Organization of the United Nations (FAO) 
Placing Collections of Plant Germplasm 
under the Auspices of FAO 
Preamble 
The [Nume #Center] (hereinafter referred to as the “Center”), 
supported by the Consultative Group on International Agricultural 
Research (hereinafter referred to as “CGIAR”), and the Food and 
Agriculture Organization of the United Nations (hereinafter referred to 
as “FAO”); 
Considering the importance to humanity of protecting and conserving 
plant germplasm for future generations; 
Considering the International Undertaking on Plant Genetic Resources 
adopted by the FAO ‘Conference at its Twenty-second Session in 1983 
(Resolution 8/83) and in particular Article 7 thereof; and the Annexes 
of the Undertaking adopted by the FAO Conference in 1989 and 1991; 
Considering that the FAO Commission on Plant Genetic Resources 
(hereinafter referred to as the “Commission”), as the relevant 
intergovernmental body in this field, has the responsibility for 
monitoring of the implementation of Article 7 of the International 
Undertaking on Plant Genetic Resources; 
Considering the Memorandum of Understanding Between the Food 
and Agriculture Organization of the United Nations and the 
International Board for Plant Genetic Resources (IBPGR) dated 
September 21, 1990, on the respective roles of the two organizations 
in establishing, maintaining, and managing germplasm collections 
and setting standards for these collections; 
Considering the strong support FAO, as one of the co-sponsors, has 
provided and continues to provide to the CGIAR; 
Considering the importance of the plant germplasm collections held 
by the International Agricultural Research Centers (IARCs) 
supported by the CGIAR, as part of a global strategy for germplasm 
conservation; 
Considering that the CGIAR adheres to a policy on plant genetic 
resources which is based on the unrestricted availability of 
germplasm held in their genebanks; 
Considering that the germplasm accessigns have been donated or 
collected on the understanding that these accessions will remain 
freely available and that they will be conserved and used in research 
on behalf of the international community, in particular the 
developing countries; 
Considering that the Center has expressed the wish that its 
designated germplasm be recognized as part of the international 
network of ex situ collections (as per the International Undertaking 
on Plant Genetic Resources) under the auspices of FAO; 
Have agreed as follows: 
Article 1 Application of This Agreement 
This Agreement shall be construed and applied in a manner 
consistent with the provisions of the Convention on Biological 
Diversity and the International Undertaking on Plant 
Genetic Resources. 
Article 2 
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Basic Undertaking 
The Center hereby places under the auspices of FAO, as part 
of the international network of ex situ collections provided for 
in Article 7 of the International Undertaking on Plant Genetic 
Resources, the collections of plant genetic resources listed in 
the Appendix hereto (hereinafter referred to as the 
“designated germplasm”), as catalogued and published by the 
Center in print of machine-readable form, in accordance with 
the terms and conditions set forth in this Agreement. The list 
of designated germplasm will be updated every two years as 
new accessions are added to the collection. 
Article 3 Status of Designated Germplasm 
(a) The Center shall hold the designated germplasm in trust 
for the benefit of the international community, in 
particular the developing countries in accordance with 
the International Undertaking on Plant Genetic 
Resources and the terms and conditions set out in this 
Agreement. 
(b) The Center shall not claim legal ownership over the 
designated germplasm, nor shall it seek any intellectual 
property rights over that germplasm or related 
information. 
Article 4 Premises 
(a) The premises in which the designated germplasm is 
conserved shall remain in the charge of the Center. 
(b) FAO shall have a right of access to the premises at any, 
time and the right to inspect all activities performed 
therein directly related to the conservation and exchange 
of the designated germplasm. 
Article 5 Management and Administration 
(a) The Center undertakes to manage and administer the 
designated germplasm in accordance with 
internationally accepted standards, including, with 
respect to the storage, exchange, and distribution of 
seeds, the international Genebank Standards endorsed 
by the Commission, as soon as possible applying the 
“preferred standards” where these are specified, and 
ensuring that all the designated germplasm is duplicated 
in order to ensure its safety. 
(b) FAO may recommend action, if it considers such action to 
be desirable, in order to ensure the proper conservation 
of the designated germplasm. 
(c) If the orderly maintenance of the germplasm collection of 
7.. 
the Center is impeded or threatened by whatever event, 
including force majeure, FAO shall assist in the 
evacuation and/or transfer of the collections, to the 
extent possible. The cost of such an operation will be 
covered by the Center concerned. 
Article 7 Staff 
Article 6 Policies 
The Center recognizes the intergovernmental authority of FAO 
and its Commission in setting policies for the International 
Network referred to in Article 7 of the International 
Undertaking and undertakes to consult with FAO and its 
Commission on proposed policy changes related to the 
conservation of, or accessibility to, the designated germplasm, 
subject, always, to the provisions ofArticle 9 hereinafter. The 
Center shall give full consideration to any policy changes 
proposed by the Commission. 
(a) Staff responsible to manage and administer the 
designated germplasm shall be employed and 
remunerated by the Center. 
(b) As and when deemed appropriate, FAO shall furnish 
technical backstopping on request by the Center. 
Article 8 Finances 
The Center shall remain entirely responsible for financing the 
maintenance of the designated germplasm. 
Article 9 Availability of Design&ted Germplasm and 
Related Information 
The Center undertakes to make samples of the designated 
germplasm and related information available directly to users 
or through FAO, for the purpose of scientific research, plant 
breeding, or genetic resource conservation, without restriction. 
Article 10 Transfer of Designated Germplasm and 
Related Information 
Where samples of the designated germplasm and/or related 
information are transferred to any other person or institution, 
the Center shall ensure that such other person or institution, 
and any further entity receiving samples of the designated 
germplasm from such person or institution, are bound by the 
conditions set out in Article 3(b) and, in the case of samples 
duplicated for safety purposes, to the provisions of Article 5(a). 
This provision shall not apply to the repatriation of germplasm 
to the country that provided such germplasm. 
Article 11 
Article 12 
Article 13 
Duration 
This Agreement is concluded for a period of four years and 
shall be automatically renewed for further periods of four 
years unless notice of non-renewal is given in writing by 
either party not less than one hundred and eighty (180) days 
before the end of any four-year period. 
Termination 
(a1 Either FAO or the Center may terminate this Agreement 
at any time by giving notice to the other, one year in 
advance of the termination date. 
(b) FAO and the Center shall, in such case, take all 
necessary measures to wind-up joint activities in an 
appropriate manner and, within the limits of their 
respective competence, to ensure the continued 
conservation of and access to the designated germplasm. 
. . 
Settlement of Disputes 
(a) Any dispute concerning the implementation of this 
Agreement shall be settled by mutual consent. 
(b) Failing mutual consent, such dispute may be submitted, 
at the request of either FAO or the Center, to an arbitral 
tribunal composed of three members. Each party shall 
appoint one arbitrator. The two arbitrators thus 
appointed shall designate by mutual consent the third 
arbitrator, who will act as the presiding arbitrator of the 
tribunal. 
(cl If within two months after the receipt of a party’s 
notification of the appointment of an arbitrator the other 
party has not notified the first party of the arbitrator he 
has appointed, the first party may request the Secretary- 
General of the United Nations to appoint the second 
arbitrator. 
(d) If within two months after the appointment of the second 
arbitrator the two arbitrators have not agreed on the 
choice of the presiding arbitrator, such presiding 
arbitrator shall be designated by the Secretary-General 
of the United Nations at the request of either party. 
(e) Unless the parties to the dispute decide otherwise, the 
tribunal shall determine its own procedure. 
(0 A majority vote of the arbitrators shall be sufficient to 
reach a decision which shall be final and binding for the 
parties to the dispute. 
Article 14 Amendment 
(a) 
(b) 
FAO or the Center may propose that the Agreement be 
amended by giving notice thereof. 
If there is mutual agreement in respect of the 
amendment, the amendment shall enter into force on 
whatever date is set, and be reported to the next session 
of the Commission. 
Article 15 Depositary 
The Director-General of FAO shall be the Depositary of this 
Agreement. The Depositary shall: 
(a) send certified copies of this Agreement to the Member 
Nations of FAO and to any other Government which so 
requests; 
(b) arrange for the registration of this Agreement, upon its 
entry into force, with the Secretariat of the United 
Nations in accordance with Article 102 of the Charter of 
the United Nations; 
(c) inform FAO members Nations of: 
(i) the signature of this Agreement in accordance with 
Article 16; and 
(ii) the adoption of amendments to this Agreement in 
accordance with Article 14. 
Article 16 Coming into Force 
This Agreement shall come into force upon signature by the 
authorized representative of FAO and the Center. 
United Naiions Food and Agriculture 
Organization 
@ame of Center] 
By: 
Date: 
(signature) 
By: 
Date: 
Isignature) 
Appendix 
Designated Germplasm 
a) List of germplasm accessions covered by this agreement 
b) List of locations where material is held 
Guidelines for the Designation 
of Accessions under 
the F’AO Agreements 
I. Background 
In October 1994, FAO and 11 CGIAR Centers (those holding plant 
genetic resources, ex situ) signed Agreements placing collections of plant 
germplasm under the auspices of FAO, as part of the International 
Network of Ex Situ Collections. Centers hold germplasm designated 
under these Agreements “in trust for the,benefit of the international 
community, in particular the developing countries in accordance with 
the International Undertaking on Plant Genetic Resources,” and the 
terms and conditions set out in the Agreements. 
Under the Agreements, each relevant Center is committed to a 
number of actions and principles; inter alia, it: 
l ” . ..undertakes to manage and administer the designated germplasm in accordance 
with internationally accepted standards, inciuding,with respect to the storage, 
exchange, and distribution of seeds, the international Genebank Standards 
endorsed by the Commission, as soon as possible applying the’preferred 
standards’where these are specified, and ensuring that all designated germplasm 
is duplicated in order to ensure its safety”(Article 5a). 
0 “ . ..undertakes to make samples of the designated germplasm and related 
information available directly to users or through FAO,for the purpose of scientific 
research, plant breeding, or genetic resource conservation,without restriction” 
(Article 9). 
Furthermore, each Center agrees that: 
l-2 ? 
0 “The Center shall not claim legal ownership over the designated germplasm, nor 
shall it seek any intellectual property rights over that germplasm or related 
information” (Article 3b). 
0 “Where samples of the designated germplasm and/or related information are 
transferred to any other person or institution,the Center shall ensure Phat such 
other person or institution, and any further entity receiving samples of the 
designated germplasm from such person or institution, are bound by the 
conditions set out in Article 3(b) and, in the case of samples duplicated for safety 
purposes, to the provisions of Article 5(a)“(Article 10). 
To date, FAO and the CGIAR have issued two Joint Statements, 
which address various issues of interpretation and implementation of 
the Agreements. In these Statements, FAO and the CGIAR agree, 
inter alia: 
0 “With respect to the transfer of samples of designated germplasm,the 
requirement of Article 10 will be satisfied by arrangements, such as material 
transfer agreements....“The wording of a standard material transfer agreement 
(MTA) for use by all Centers has been agreed by FAO and the CGIAR. 
l That Centers will follow certain specified procedures when they have reason to 
believe that an MTA may have been violated. 
l That Centers are not expected to meet unreasonable requests for germplasm 
(either in terms of quantity of accessions requested or the amount of material 
requested of a single accession), nor are they obliged to transfer material when 
such a transfer would pose a risk of introducing pests or diseases. 
On their own initiative, Centers designate germplasm to be 
included in the International Network and under the terms and 
conditions of the Agreements with FAO. Germplasm acquires its 
status as “designated” germplasm at the moment the Center 
determines that it considers it as such, and is willing to manage it in 
accordance with the FAO Agreements. Every two years, Centers are 
required to provide FAO with an updated list of designated 
germplasm. It is recognized in the second Joint Statement that in 
certain circumstances, specific designated germplasm will cease to be 
considered as designated (e.g., loss of viability of an accession, and 
administrative situations such as the discovery that an accession 
identifier previously provided FAO does not actually correspond to a 
physical sample, etc.) 
The Agreements call for the Centers to append a list of 
“designated germplasm” included in the International Network, and 
to update the list every two years as new accessions are added to the 
collections. 
These Guidelines for Designation have been developed on the 
initiative of and through the System-wide Genetic Resources Program 
and endorsed by the Inter-Center Working Group on Genetic 
Resources. The promulgation of these Guidelines demonstrates that 
Centers accept a certain responsibility towards the international 
community to designate materials under the Agreements with FAO in 
a consistent and transparent manner, and on the basis of clearly 
enunciated criteria. While these Guidelines are aimed at helping 
Centers determine whether to designate materials under the FAO 
Agreements and at making that decision-making process more 
transparent to the general public, it should be noted that a number of 
other documents have relevance to the Agreements themselves and to 
their implementation, inter alicz, the FAO-CGIAR-agreed Material 
Transfer Agreement (MTA), the first and second “Joint Statement(s) of 
FAO and the CGIAR Centers on the Agreement Placing CGIAR 
Germplasm Collections under the Auspices of FAO,” and certain other 
CGIAR policies and statements concerning plant genetic resources and 
intellectual property rights. 
II. Criteria to Consider in Determining Whether 
Material Should Be Designated 
For decades, Centers have safeguarded genetic diversity and 
attempted to develop it in the public interest. Centers have never 
claimed to own this genetic material. In keeping with this tradition and 
practice, Centers now designate material if it is eligible for designation 
(i.e., not acquired with restrictions preventing a Center from managing 
it in accordance with the FAO Agreements), and, as noted below, if the 
Center is prepared to manage it in accordance with the Agreements. 
Centers should not consider the value or potential usefulness of the 
material, nor attempt to make any value judgement about whether the 
material should be in the public domain, or not, when deciding whether 
to designate an accession. 
The understanding and principle underlying the Agreements with 
FAO is that each Center will designate all accessions (see Section III, 
below, for more detail) that are part of their holdings, or are 
subsequently acquired, which have not already been designated by 
another Center or institution and which will be administered and 
managed by the Center in compliance with the terms and conditions of 
14 the Agreement with FAO. 
In designating germplasm, Centers commit 
themselves to: 
a. long-term conservation, and 
b. unrestricted availability. 
The CGIAR Policy on Genetic Resources (1989) declared for the first 
time that collections were being held “in trust” for the world community. 
Implicit in such a declaration-and explicit in the Agreements with 
FAO-is the understanding that Centers do not claim ownership of this 
genetic material. Thus, Centers have a responsibility to designate all 
germplasm which (1) they undertake to conserve under accepted 
standards (in most cases, long-term); and (2) they can make available 
without restriction for “scientific research, plant breeding, or genetic 
resource conservation.” (See Section V below for a more detailed 
treatment of how Centers should interpret the term “without 
restriction.“) 
III. Types of Germplasm to Be Designated 
Accessions that a Center is prepared to conserve long-term and 
make available without restriction should be designated irrespective of 
whether they are wild species, landraces, farmer varieties, obsolete 
varieties, advanced varieties, breeding lines, genetic stocks, etc. In cases 
where materials have been received with the understanding that they 
will be conserved and will remain available, it is incumbent upon the 
Center to designate them. It is understood that Centers may have sound 
scientific and management reasons for not designating all breeding 
lines, experimental populations, genetic stocks, or products of breeding 
programs such as advanced cultivars. Commitment to long-term 
conservation and unrestricted availability may not be appropriate in all 
such cases. In such circumstances, the material in question would not 
be designated. Non-designation, however, would not prevent the Center 
from making the material available appropriately and at the proper 
time in furtherance of Center and CGIAR goals and principles. 
Accessions held by Centers for others under “black box” 
arrangements should not be designated. (Some Centers hold “black box” 
collections-collections of others who may be temporarily unable to care 
for the material. In these cases, the Center typically conserves the 
material but usually does not open, examine, test, or engage in research 
on the materials. While the Center may be committed to long-term 
storage of such materials, the Center has no right or authority to 
designate them.) 
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Furthermore, Centers should endeavor to designate particular 
accessions only once-confusion will result if accessions and their 
duplicates stored at other Centers are all designated. 
A. Accessions acquired by the Center before the coming into force of the 
Convention on Biological Diversity (29 December 1993) 
In the vast majority of cases, materials acquired before 29 December 1993 were, in 
fact, acquired with the understanding that they would enter the collection of the 
Center, be conserved, and be made available to all bona fide users.Such materials 
should be designated. In some cases (e.g., advanced products of formal breeding 
programs), materials may have been acquired with certain restrictions regarding 
their use or distribution. Such materials should not be designated, as the Center 
could not meet the requirements of the Agreements with FAO. 
B. Accessions acquired by the Center afterthe coming into force of the 
Convention on Biological Diversity (29 December 1993) 
Materials acquired afterthe coming into force of the CBD can and ordinarily should 
be designated under the Agreements with FAO provided they have been acquired 
with the understanding that they will remain in the”public domain”and that the 
Center will conserve them and make them available without restriction as called for 
in the FAO Agreements. In such a case, the same principles guiding the designation 
of pre-CBD materials apply: the Center must intend to manage and administer the 
material in accordance with the FAO Agreements.CentraI to the decision to 
designate post-CBD-acquired material (as with pre-CBD-acquired materials) is that 
the Center be willing to commit to long-term conservation and unrestricted 
availability. 
It is understood that acquisition of materials should be based on the 
express written permission of the relevant government authority. 
Centers should seek to determine which institute or agency has this 
legal authority. If materials are acquired with restrictions on their access 
or use, then it follows that they cannot be designated. Materials held 
with such restrictions cannot be considered as being kept by the Center 
“in trust for benefit of the international community...” (Article 3a). 
IV. Conservation of Designated Germplasm 
The FAO-CGIAR Agreements state: “The Center undertakes to 
manage and administer the designated germplasm in accordance with 
internationally accepted standards, including, with respect to the 
storage, exchange, and distribution of seeds, the international genebank 
standards endorsed by the Commission, as soon as possible applying the 
‘preferred standards’ where these are specified, and ensuring that all 
the designated germplasm is duplicated in order to ensure its safety” 
(Article 5). This means, in effect, that Centers must endeavor to 
conserve materials in a manner consistent with international 
standards, adopting “preferred standards” (i.e., those most appropriate 
for long-term conservation of the material in question) as quickly as 
possible. 
The decision about whether or not to designate material should be 
made without regard to the form in which the material is to be 
conserved (seed, in vitro culture, whole plant, other) or the current/ 
initial technical conditions of storage (long-term, medium-term, 
cryopreserved, etc.). 
v. Availability of Designated Germplasm 
and Related Information 
Designation can apply only to accessions that are available without 
administrative, legal, or policy restriction. In other words, the 
availability of germplasm cannot be limited by contractual agreements 
with the supplier of the germplasm, by intellectual property laws, or by 
any policy or administrative regulation of the Center (with the exception 
of relevant health and quarantine regulations). 
Accessions should be designated irrespective of any current technical 
constraints to making them physically available, In a Second Joint 
Statement issued by FAO and the CGIAR, it was agreed that Centers 
could not be expected to till all requests for materials immediately, or fill 
requests for unreasonable numbers of accessions or quantity of seed or 
clones, for example. It was agreed that Centers should not distribute 
designated germplasm when such distribution posed a risk of 
introducing pests and/or diseases. In other words, it is understood that ,. 
certain factors may constrain the ability of a Center to distribute 
designated materials-the fact that an accession may be temporarily 
unavailable does not affect the decision to designate it, or its status as 
designated later. The Agreements with FAO call for a good faith 
approach to the Agreements on both the part of the party requesting 
materials and the Centers. (See the Second Joint Statement for more 
detailed information on this subject.) 
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Germplasm Acquisition 
Agreement (GAA) for Material 
Intended for Designation 
1. 
2. 
3. 
4. 
5. 
[Nation or Supplier] grants germplasm and related information to 
[Center] under the terms and conditions of this agreement. The 
germplasm being provided is identified in the attached list which 
forms part of this agreement. 
[Nation or Supplier] warrants that it is legally free to provide the 
germplasm to [Center], that [Nation] is the country of origin of the 
germplasm, and that all necessary permissions have been obtained. 
[Center] will hold the germplasm in trust under the terms of an 
agreement between the [Center] and FAO, place it in its genebank, 
periodically regenerate it, duplicate it for security reasons, and 
provide long-term conservation. 
[Center] will be free to make the germplasm and related information, 
its progeny, and genes in it available to any third party for 
agricultural research purposes, but may do so only under a material 
transfer agreement, with terms intended to restrict the recipient from 
obtaining intellectual property rights on the material itself and to 
require similar commitments from any further recipients. 
[Center] obligations of paragraph 4 of this agreement shall expire at 
the end of 30 years after the date of the agreement. 
Signed Signed 
Transfer of Designated 
Germplasm: 
Important Notice 
On October 26,1994, the [Center] signed an agreement with the 
United Nations Food and Agriculture Organization placing germplasm 
collections maintained by [Center] under the auspices of FAO, as part 
of the international network of ex situ collections provided for in 
Article 7 of the International Undertaking on Plant Genetic Resources, 
to be held in trust by [Centerl. The Agreement is attached herewith. 
The Agreement recognizes the intergovernmental authority of FAO 
and its Commission on Plant Genetic Resources in setting policies for 
the International Network referred to in Article 7 of the International 
Undertaking on Plant Genetic Resources. The materials covered by 
the Agreement are listed as “designated germplasm” in an annex to 
the Agreement. “Designated Germplasm” is indicated as such on the 
seed list attached to the Shipment Notice, and on each packet of seeds. 
[Center-l has traditionally adhered to a policy of unrestricted 
availability of germplasm held in its genebank( In the interest of 
keeping this material available for future research and utilization, 
[Center/ has undertaken, under Article 3(b) of the Agreement with 
FAO, not to claim legal ownership over the designated germplasm, or 
to seek any intellectual property rights over that germplasm or related 
information. To ensure continued free availability of designated 
germplasm, [Center] has also agreed to pass on the same obligations to 
all future recipients of designated germplasm. 
Accordingly, the recipient must agree: 
a) not to claim ownership over the designated germplasm received, or to seek 19’ 
intellectual property rights over that germplasm or related information; 
b) to ensure that any subsequent person or institution to whom he or she makes 
samples of the germplasm available, is bound by the same provision. 
d to assume full responsibility for complying with the recipient nation’s quarantine/ 
biosafety regulations and rules as to import or release of genetic material. 
The phytosanitary condition of the material is warranted only as 
described in the attached phytosanitary certificate. K’enterl makes no 
warranties as to the safety or title of the material, nor as to the 
accuracy or correctness of any passport or other data provided with the 
material. Neither does it make any warranties as to the quality, 
availability, or purity (genetic or mechanical) of the material being 
furnished. 
Rules for the future exchange of plant germplasm for food and 
agriculture are currently being debated in the FAO Commission on 
Genetic Resources in coordination with the Conference of the Parties to 
the Convention on Biological Diversity. [Center] and the Consultative 
Group on International Agricultural Research (CGIAR) are actively 
participating in this debate with the aim of assuring that any future 
arrangements will facilitate exchange and utilization of this precious 
global resource and the fair and equitable sharing of the benefits 
derived from the commercial or other utilization of the germplasm. 
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[Center] 
Standard Order Form 
Consecutive Number: SOFlYearlNumber 
I/we order the following material: 
In so far as this material is “designated germplasm” under the 
Agreement between [Center] and the Food and Agriculture Organization 
of the United Nations (FAO) Placing Collections of Plant Germplasm 
under the Auspices of FAO dated 26 October 1994 * 
I/we agree: 
a) not to claim ownership over the material received, nor to seek intellectual property 
rights over that germplasm or related information; 
b) to ensure that any subsequent person or institution to whom I/we make samples 
of the germplasm available, is bound bythe same provision. 
Place/date 
Name of person or Institution requesting the germplasm 
Address 
Shipping address (if different from the above) 
Authorized signature 
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+ Whether or not the material is “designated germpiasm”wiii be indicated on the seed list attached 
to the Shipment Notice and on rhe seed packets. 
[Center] 
Shipment Notice 
Consecutive Number: SNIYearlNumber 
In response to your request signed and dated . . . you are receiving 
with this notice the following germplasm samples as indicated on the 
attached seed list. 
[Center] does not warrant the safety, quality, viability, or purity 
(genetic or mechanical) of the germplasm nor the accuracy of passport or 
other data provided with it. Its phytosanitary condition is only 
warranted as described in the attached phytosanitary certificate. 
It is the recipient’s responsibility to comply with the recipient’s 
country biosafety and import regulations and any of the recipient’s 
country rules governing the release of genetic material. 
Please note that samples indicated as “Designated Germplasm” on 
the seed list or on the seed packets are subject to the Agreement 
between [Center] and the Food and Agriculture Organization of the 
United Nations (FAO) Placing Collections of Plant Germplasm under 
the Auspices of FAO, dated 26 October 1994, and are thus subject to the 
following conditions: 
a) The recipient agrees not to claim ownership over the material received nor to seek 
intellectual property rights over that germplasm or related information. 
b) The recipient agrees to ensure that any subsequent person or institution to whom 
the recipient makes samples of the germplasm available, is bound by the same 
provision. 
Date 
(Signature) 
(Name and title) 
Material Transfer Agreement 
The material contained herein is being furnished by [Center] 
under the following conditions: 
Designated Germplasm 
[Center-l is making the material described in the attached list 
available as part of its policy of maximizing the utilization of genetic 
material for research. The material was either developed by [Centerl; or 
was acquired prior to the entry into force of the Convention on 
Biological Diversity; or if it was acquired a&r the entering into force of 
the Convention on Biological Diversity, it was obtained with the 
understanding that it could be made freely available for any 
agricultural research or breeding purposes. 
The material is held in trust under the terms of an agreement 
between [Center] and FAO, and the recipient has no rights to obtain 
Intellectual Property Rights (IPR) on the germplasm or related 
information. 
The recipient may reproduce the seed and use the material for 
agricultural research and breeding purposes and may distribute it to 
other parties provided the recipient is also willing to accept the 
conditions of this agreement. f 
The recipient, therefore, hereby agrees not to claim ownership over 
the germplasm to be received, nor to seek IPR over that germplasm or 
related information. He/she further agrees to ensure that any 
subsequent person or institution to whom he/she may make samples of 
the germplasm available, is bound by the same provision and 
undertakes to pass on the same obligations to future recipients of the 
germplasm. 
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+ This does not prevent the recipient from releasing or reproducing the seed for purposes of making it 
direct/y available to farmers or consumers for cultivation,provided that the other conditions set out 
in the MTA are complied with. 
[Ceder] makes no warranties as to the safety or title of the 
material, nor as to the accuracy or correctness of any passport or other 
data provided with the material. Neither does it make any warranties 
as to the quality, availability, or purity (genetic or mechanical) of the 
material being furnished. The phytosanitary condition of the material is 
warranted only as described in the attached phytosanitary certificate. 
The recipient assumes full responsibility for complying with the 
recipient nation’s quarantine/biosafety regulations and rules as to 
import or release of genetic material. 
Upon request, [Center] will furnish information that may be 
available in addition to whatever is furnished with the seed. Recipients 
are requested to furnish [Center] performance data collected during 
evaluations. 
The material is supplied expressly conditional on acceptance of the 
terms of this Agreement. The recipient’s acceptance of the material 
constitutes acceptance of the terms of this Agreement. 
Second Joint Statement of FAO and 
the CGIAR Centers 
on the Agreement Placing CGIAR 
Germplasm Collections 
under the Auspices of FAO 
A Joint Statement issued by FAO and the CGIAR in 
conjunction with the signing of the FAO-CGIAR 
Agreements Placing CGIAR Germplasm Collections under 
the Auspices of FAO observed that: 
The parties to the Agreement recognize that the conclusion of the Agreements 
represents but one stage of a continuing, dynamic process and agree to 
continue the dialogue in the context of the implementation of the Convention 
on Biological Diversity and the FAO Global System on Plant Genetic Resources. 
They will consult from time to time to review these matters and to consider such 
modification as may be appropriate in the circumstances. 
FAO and the CGLAR have consulted frequently since the 
Agreements were concluded in 1994 in order to review the 
implementation of the Agreements. 
The Parties understand and agree that: 
While Centers distribute germplasm designated under the FAO- 
CGIAR Agreements through Material Transfer Agreements {MT&) 
which prohibit the recipient, or any subsequent recipient, from taking 
out intellectual property rights, the CGIAR cannot guarantee that 
recipients will abide by the terms of the MTA. Violations may take 
place. However, in such cases the Parties commit themselves to taking 
appropriate remedial action, in accordance with the following agreed 
procedures. 
_ . 
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When Centers become aware of a possible violation of their MTAs 
by a recipient of germplasm, the Centers will henceforth voluntarily 
undertake the following actions in response to the perceived violation: 
1. The Centers will request an explanation. Upon failure to receive a satisfactory and 
timely explanation for the situation from the germplasm recipient, the Centers will 
notify the recipient that a violation is thought to have occurred and request that 
the recipient cease and desist in its efforts to obtain intellectual property rights 
over the material, or renounce such rights or ownership if they have already been 
granted or claimed. 
2. The Centers will notify the proper regulatory body in the relevant country of the 
possibility that the MTA has been violated, and bring to their attention the fact 
that the grant of intellectual property rights may,therefore, have been 
inappropriate in the case of the material obtained from the CGIAR. 
3. The Centers will notify IPGRI and the FAO Commission on Genetic Resources for 
Food and Agriculture, through its Secretariat,of the possible violation of the MTA 
under the Agreements with FAO. 
The Centers reserve the right to take other action, including legal 
action, as they might deem feasible and appropriate to enforce the 
MTAs and preserve the integrity of the Agreements with FAO. In this 
regard, it would be the intent of the Centers to work in cooperation 
with FAO, under whose auspices the materials are held in trust by the 
CGIAR for the benefit of the international community. 
The Centers recognize that many accessions designated under the 
Agreements with FAO, were distributed to plant breeders and 
researchers prior to designation in keeping with the CGIAR policy for 
providing “unrestricted availability” to germplasm-as noted in the 
Preamble of Agreements. In dealing with this situation, Centers will 
request and urge that no intellectual property rights be sought for 
designated germplasm that was distributed prior to its designation 
under the FAO-CGIAR Agreement. 
Periodic reports will be presented to the Commission on Genetic 
Resources for Food and Agriculture on the actions taken in support of 
the objectives of the Agreements between the CGIAR Centers and FAO. 
In considering the text of the Agreement, the common 
understanding of the parties concerning certain of its provisions is, as 
fQllows: 
Under the terms of the Agreements (Article 9), the Centers undertake’?0 make 
samples of the designated germplasm available directly to users or through FAO 
for the purpose of scientific research, plant breeding, or genetic resource 
conservation,without restriction.“It is implicit in this undertaking that users will 
make only reasonable requests for these specific purposes, and that the liability of 
the Centers would not extend to the fulfillment of unreasonable requests. 
Sound management practices as well as practical or even biological constraints 
(such as seed availability or the health status of a sample) may at times make it 
difficult or inappropriate for Centers to provide germplasm designated under the 
Agreements for the purposes spel!ed out in Article 9. It is understood that Centers 
must use some discretion in determining the size and number of samples to be 
provided at any given time to a particular recipient.Centers are not obligated to 
distribute seed or other designated materials when such distributions would 
reduce stocks below accepted levels for conservation purposes, or when the 
request is for such a number of samples or quantity of a particular accession as to 
pose an undue burden on the financial or technical resources of the Center or on 
its ability to meet requests from others. In such cases, the Center may ask that the 
recipient cover the actual costs of multiplying the relevant accessions. In cases of 
limited supplies,immediate availability of materials cannot be guaranteed.Such 
availability will follow a process of multiplication.Centers are not obligated to 
supply quantities of a sample which exceed basic requirements for the purposes 
stated in Article 9. Recipients are advised that they may need to undertake their 
own seed multiplication when existing sample sizes are small (such as is the case 
with many accessions of wild relatives) or when demand for a particular sample 
exceeds supply.In filling requests for material forconservation purposes alone, 
users are invited to note the Global Plan of Action’s objectives of’safeguarding as 
much existing unique and valuable diversity as possible in exsitu collections,“while 
reducing “unnecessary and unplanned redundancy in current programmes.” 
In cases when a Center cannot fully or immediately meet a request, the Center will 
enter into a discussion with the requesting entity to develop and agree upon a 
plan and schedule for the supply of materials.This process might establish an 
agreed list of accessions to which priority would be given. 
Some designated accessions cannot be multiplied without considerable cost. For 
example, certain accessions of woody species may take upwards of 10 hectares of 
land and 30 years to multiply. Similarly, supplying materials of vegetatively 
propagated species can involve very time-consuming and expensive procedures. 
While Centers endeavor to supply materials free of cost, in such circumstances it 
would be unreasonable to expect that Centers could guarantee unlimited 
quantities or immediate availability of all designated germplasm. Users are 
encouraged to exercise good judgement and appropriate constraint in requests for 
such materials.At their discretion, Centers may request that users cover all or part 
of the costs involved in multiplication. 
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Centers are neither obligated nor advised to distribute samples that do not meet 
health or quarantine standards, or whose transfer could pose the danger of a 
spread of pests or disease.Centers will inform those requesting materials of the 
danger which might be posed by invasiveness in those cases where they perceive 
such dangers to be significant, and of the need for the prior informed consent of 
the recipient Government for the import of such materials. Materials will then be 
supplied upon receipt of such prior informed consent. 
Article 2 provides that”The list of designated germplasm will be updated every 
two years as new accessions are added to the collection.“This does not preclude 
Centers from adding new germplasm to the list of designated germplasm without 
having to wait for the biennial updating of the lists. In such cases,the status of 
particular germplasm as”designated germplasm” becomes effective immediately 
upon a Center’s determining that it is designating the germplasm under the 
Agreement and managing the germplasm under the terms of the Agreement.The 
additional designations will be consolidated into updated lists,which will be 
notified to FAO every two years or more frequently as may be appropriate. 
As management and information systems improve and as genomic information 
about accessions becomes available,Centers will update the list of materials 
covered under the Agreements. In addition to adding new materiaIs,Centers may 
find,for example,that particular accessions have been designated more than once; 
that an accession’s registration number conveyed to FAO on the list of designated 
germplasm referred to in Article 2, may be incorrect or no longer correspond to an 
actual accession in the Center’s genebank;or that an accession.may, through 
natural or accidental causes, have lost viability. Logically, such”accessions”will no 
longer be considered as designated under the terms of the AgreementThe Center 
or Centers concerned will notify FAO of any proposals for the deletion of accessions 
from the list of designated germplasm for such reasons and will provide FAO with a 
statement of the reasons therefore. 
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Guiding Principles for the Consultative 
Group on International Agricultural 
Research Centers on Intellectual Property 
and Genetic Resources t 
Background 
The CGIAR is committed to the conservation and use of genetic 
resources in an expeditious, cost-effective, and equitable manner. In 
recent years the CGIAR’s activities have been increasingly conditioned 
by a rapidly changing intellectual property rights (IPR) environment, 
the issue of Farmers’ Rights, and the growing importance of the private 
sector. In this context, the CGIAR, at its Mid-Term Meeting, Istanbul, in 
May 1992, agreed on a set of working principles on genetic resources and 
intellectual property. These were published in the proceedings of the 
meeting and were largely based on a set of guiding principles on plant 
genetic resources and related IPR issues adopted by the IAFKs in 1991. 
Significant changeshave occurred since the CGIAR decisions in 1992 
that affect the exchange and use of genetic resources: 
l The Convention on Biological Diversity (CBD) came into force 29 December 1993. 
l Centers signed Agreements with FAO on 26 October 1994 bringing their 
germplasm collections under the auspices of FAO as part of the International 
Network of .&Situ Collections. Materials covered in these Agreements, referred to as 
designated germplasm, * are listed in the appendices to the Agreements. 
l The Multilateral Trade Agreement that came into force 1 January 1995 embodies 
provisions on Trade-Related Intellectual Property Rights (TRIPS). As a result, many 
countries are now developing and enacting IPR legislation, including plant variety 
protection. 
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f This document was adopted as an interim working paper by the CGIAR at its ICW’96 meeting, 
Washington, DC. 
# The majority of materials currently held in Center genebanks has already been designated as 
coming under the agreement with FAO. Further materials are being designated (as stocks are 
cleaned and multiplied) with the result that only those materials carrying special conditions 
imposed by the supplier would remain undesignated. In 1996, such materials accounted for less 
than 5% of the total holdings. 
Against this background, the CGIAR convened a panel on IPR in 
September 1994 under the Chairship of MS. Swaminathan. The report 
of the panel was endorsed at International Centers Week in October 
1994. 
Based on the agreed recommendations made in this report and 
pending the emergence of international consensus on a range of issues 
arising, the CGIAR Centers have revised their guiding principles on 
intellectual property. While it is envisaged that there may well be 
further revisions as changing circumstances warrant, the Centers 
consider it essential to clearly state these guiding principles for the 
benefit of the national agricultural research systems (NARS), donors, 
non-government organizations (NGOs), the private sector, and our other 
partners in research and development. 
Guiding Principles 
l The germplasm designated by the Centers is held in trust for the world community 
in accordance with the agreements signed with FAO.Through the agreements, 
official intergovernmental recognition is given to this role of the Centers, and FAO is 
to provide policy advice to the Centers inthe execution of their responsibilities.The 
Centers agree to conserve, maintain, study, improve, and distribute germplasm 
worldwide for use in agricultural research and development.As trustees of the 
designated germplasm, the Centers also affirm their responsibility for safe and 
secure conservation ofthese genetic materials for present and future generations, 
including their duplication in at least one other location for safety. 
l Through their guiding principles on intellectual property protection,the Centers 
aim to promote ready access to both the designated germplasm and the Centers’ 
research products including biotechnological processes arising from their research. 
National Sovereignty 
30: 
l The Centers recognize that the acquisition of germplasm after the coming into 
force of the CBD is subject to the provisions of the said Convention and in particular 
to the sovereign rights of states over their genetic resources.The Centers will strive 
to reach an understanding on mutually agreed terms with national governments, 
either individually or collectively,facilitating the fair and equitable Benefits Sharing 
arising from the collection, conservation, and use of such germplasm besides 
providing ready access to these genetic resources. 
Farmers’ Rights 
l The Centers recognize the contributions of farming and indigenous communities to 
genetic resources conservation and enhancement. In order to convert this concept 
into reality, the Centers are prepared to contribute to national and international 
efforts to develop appropriate policies and procedures for the recognition of 
Farmers’Rights.The Centers also recognize the expertise of many national and 
international NGOs on equity, gender, conservation, and sustainability issues and, 
where appropriate, encourage partnerships with them and others in order to 
integrate these concerns in research on genetic resources conservation and use. 
Intellectual Property Protection: 
Designated Germplasm and Center Research Products 
The Centers will not claim legal ownership nor apply intellectual property 
protection to the germplasm they hold in trust,and will require recipients of the 
germplasm to observe the same conditions in accordance with the agreements 
signed with FAO. 
Plant Breeders’ Rights. Materials supplied by the Centers, whether designated 
germplasm or the products of the Centers’breeding activities, may be used by 
recipients for breeding purposes without restriction. Recipients, including the 
private sector, may protect the products of such breeding through plant variety 
protection that is consistent with the provisions of the International Union for the 
Protection of New Varieties of Plants (UPOV) or any other suigeneris system, and 
that does not preclude others from using the original materials in their own 
breeding programs. 
Defensive Protection by Centers. Based on the conviction that their research will 
continue to be supported by public funds, the Centers regard the results of their 
work as international public goods. He,nce,full disclosure of research results and 
products in the public domain is the preferred strategy for preventing 
misappropriation by others. Consequently, the Centers will not assert intellectual 
property control over derivatives except in those rare cases when this is needed to 
facilitate technology transfer or otherwise protect the interests of developing 
nations. In all such cases, the Centers will disclose the reasons for seeking 
protection. 
The Centers do not see the protection of intellectual property as a mechanism for 
securing financial returns for their germplasm research activities and will not view 
potential returns as a source of operating funds. In the event that a Center secures 
financial returns as a result of the commercialization by others of its protected 
property, appropriate means will be used to ensure that such funds are used for 
furthering the mandate of the Center and the objectives of the CGIAR. 
Any intellectual property protection of Centers’output will be done on behalf of 
the Centers and not individual scientists.All staff in the Centers will be required to 
disclose innovations and assign all rights on these to the Centers. 
Patenting.We recognize that there is an increasing use of patenting in both the 
private and public sectors.Cells, organelles, genes, or molecular constructs isolated 
from materials distributed by Centers may be protected by recipients only with the 
agreement of the supplying Center. Centers wiil give such approval only after 
0 
consultation with the country,or countries,of origin ofthe germplasm where this is 
known or can be readily identified.This consultation would include consideration 
of an appropriate Benefits Sharing, whether bilateral or multilateral, flowing from 
subsequent commercial development of the protected material + and would 
require that the original material remains available for the public good. 
Center Access to Material Protected by Others.To promote the availability to 
developing nations of germplasm and scientific innovations that have been 
protected by others, the Centers may enter into agreements with the holders of 
such rights.Acceptance of any limitations on the distribution and use of derived 
and associated materials would have to be consistent with the goals and 
objectives of the CGIAR, and the benefits of such agreements should outweigh the 
potential disadvantages. 
Biosafety 
l The Centers will continue to give overriding importance to biosafety concerns and 
will follow collaborating country guidelines concerning biosafety. 
General Procedures 
l These Guiding Principles will be reviewed at regular intervals and revised as need 
be in the light of international developments.This revision will be carried out by 
the Center Directors Committee. 
l The Centers will adopt specific policies for the distribution and use of improved 
germplasm and biotechnological products following the above Guiding Principles. 
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t It is recognized that this requirement for the granting ofpermission by a Center before a recipient can 
rake our patent protection represents a significant departure from the current position in which the 
Centers do nor require any such permission. While rhis is nor specifically required under the terms of the 
agreements signed with FAO, nevertheless the CGlAR fee/s that such a requirement is needed both to 
protect the interests of the Countries of Origin and to bring CGIAR policy in line with the spirit of the CBD. 
While the CGlAR Centers cannot themselves be party to the Convention, it is nevertheless recognized that 
the majority of CGlAR members and partner countries have signed and ratified the CBD. 
Principles Involving CGIAR 
Center Interaction with 
the Private Sector and Others 
l The CGIAR Centers recognize the increasing importance of the private sector and 
other institutions in the invention and development of materials and advanced 
technologies that could be applied to the CGIAR goals of alleviation of poverty, 
enhancement of food security, and protection of natural resources. 
l The CGIAR Centers engage the private sector, universities,advanced research 
institutes, NARS,and other institutions to access these materials and technologies 
and bring them to bear on the problems and opportunities of poor farmers.This 
may include licensing of products and technologies and engaging in partnerships 
to develop and deliver new technology to poor farmers and others in developing 
countries. 
l CGIAR Centers derive benefits from relationships with other institutions and the 
private sector through access to and use of: 
0 proprietary technology and expertise (know-how); 
0 proprietary materials, reagents, and products; 
0 manufacturing and production capabilities; and 
0 delivery systems for research and information products. 
l Centers’collaboration with other institutions will be conducted in accordance with 
the CGIAR Ethical Principles Relating to Genetic Resources which have been 
adopted formally at MTM’98. In the event Centers secure financial returns as a 
result of commercialization by others of protected property, they will be applied to 
furthering the mandate of Centers involved and the objectives of the CGIAR. 
l The Guiding Principles for the CGIAR International Agricultural Research Centers on 
Intellectual Property and Genetic Resources (agreed to informally as operating 
guidelines during MTM’96) will apply to all agreements with the private sector and 
other institutionsThese principles define or describe responsibilities related to 
germplasm held in trust by the Centers,as well as ensuring broad access to 
designated germplasm and Centers’research outputs, including biotechnological 
research processes and products.These principles specify the responsibilities and 
procedures for Centers in dealing with: 
0 national sovereignty (rights of states over their genetic resources); 
; 
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0 farmers’ rights; 
0 intellectual property protection for designated germplasm and Center 
research products; 
0 plant breeders’ rights; 
0 defensive protection by Centers; 
0 patenting; 
0 Center access to materials protected by others;and 
0 biosafety and bioethics. 
l In collaboration with industry or other institutions, Centers will adhere to policies 
and procedures for the conservation and use of genetic resources and 
biodiversity as defined under the terms of the: 
0 Convention on Biological Diversity; 
0 FAO-CGIAR Agreement on Genetic Resources; and 
0 FAO International Undertaking on Plant Genetic Resources for Food and 
Agriculture. 
l In compliance with contemporary legal and ethical obligations, Centers will 
undertake good faith negotiations with owners of proprietary technologies they 
use or plan to use, including patented materials and processes, protected 
trademarks, protected varieties, copyrighted materials, and legally protected trade 
secrets 
l The Chair of the CGIAR or his designee is entrusted to represent and protect the 
interests of the CGIAR and its Centers in international decision-making for a, 
including but not limited to the WorldTrade Organizations (WTO), (specifically 
with respect toTRIPS),World Intellectual Property Organization (WIPO),CBD, 
UPOV, and FAO. 
May28,1998 
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CGIAR Centers’ Position 
Statement on Biotechnology 
Given the immensity of the long-term food security and 
environmental conservation challenges confronting countries of the 
South, the Centers firmly believe in the following propositions: 
l Biotechnology must be viewed as one of the critical tools for providing food 
security for the poor. 
l The Centers advocate the prudent application of the full range of biotechnology 
tools to achieve substantial and sustainable growth in agricultural productivity in 
poor CountriesThese tools include, but are not limited to, molecular markers, 
genetic engineering, and recombinant vaccines. 
l The Centers view biotechnology as an essential means for ensuring environmental 
protection over the long term. 
l The Centers have a clear comparative advantage in ensuring access by the 
countries of the South to the advanced tools of biotechnology.This advantage 
accrues by virtue of the Centers’present credible mass in biotechnology, their 
global network of partnerships within and among countries of the South, and their 
increasingly close linkages to advanced research institutions (ARls) of the North, 
both public and private. 
l Given the extremely rapid pace of new developments in biotechnology,the 
Centers are committed to increasing their partnerships with ARls, both public and 
private, North and South, to ensure ready access of Center scientists and our 
partners in the South to advanced technologies. 
l The Centers make adequate investments in the arena of biotechnology in order to: 
1) maintain their own credible scientific mass;2) be proactive in assisting countries 
of the South to establish effective biosafety regulations; and 3) contribute 
substantially to developing the human capital needed to ensure the judicious 
application of appropriate biotechnology tools to important food security and 
environmental problems. 
l The Centers are firmly committed to the application of genomics (molecular 
genetics, molecular markers) for immediate use in better understanding and 
manipulating the genomes of plants, animals, and their pathogens and pests. 
l The development and deployment of transgenics (via genetic engineering) is seen 
by the Centers to providelmportant options for meeting the food security and 
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environmental challenges ofthe future. 
e The Centers will carry out all of their activities in the arena of biotechnology under 
high standards of appropriate and approved biosafety regulatory frameworks, 
both within individual countries and institutions.The Centers will seek partnerships 
with institutes that have such frameworks in place (thus our commitment to policy 
and capacity-building in this area). 
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